NASDAQ:URGN
Wall Street analysts’ outlook for UroGen Pharma Ltd (URGN)
Colin Adrian
With 1.37 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.21 million ...
Does UroGen Pharma Ltd (URGN) offer a good opportunity for investors?
Cody Benson
With 1.67 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.28 million ...
